GHK-Cu + matriquinas (Matrixyl): formulaciones cosmticas avanzadas
Mono-agonici (jak Semaglutyd) dziaaj wycznie na o GLP-1, a agonici podwjni (jak Tirzepatyd) cz GLP-1 i GIP
One analysis used pooled data from five randomized placebo-controlled trials in which ginkgo, at 240 mg daily for 2226 weeks, was tested as a therapy for dementia
Patients taking insulin glargine experienced injection site reactions, including redness, pain, itching, urticaria, edema, and inflammation
Pilot RCTs in relapsing MS report modest EDSS improvement and lower corticosteroid need, suggesting that simultaneous enhancement of oxidative phosphorylation, NAD + cycling and membrane repair may decelerate disability accrual (41, 84)